Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element
Lab / animal
OA: bronze
CC0
⤵ 115 in-corpus citations
AI-generated summary
Steroidogenic factor-1 and COUP-TF compete for the same cis-acting element, with SF-1's presence in endometriosis driving aromatase expression while COUP-TF's in endometrium inhibits it.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
In stromal cells of endometriosis, marked levels of aromatase P450 (P450arom) mRNA and activity are present and can be vigorously stimulated by (Bu)2cAMP or PGE2 to give rise to physiologically significant estrogen biosynthesis. Since eutopic endometrial tissue or stromal cells lack P450arom expression, we studied the molecular basis for differential P450arom expression in endometriosis and eutopic endometrium. First, we demonstrated by rapid amplification of cDNA 5'-ends that P450arom expression in pelvic endometriotic lesions is regulated almost exclusively via the alternative promoter II. Then, luciferase reporter plasmids containing deletion mutations of the 5'-flanking region of promoter II were transfected into endometriotic stromal cells. We identified two critical regulatory regions for cAMP induction of promoter II activity: 1) a-214/-100 bp proximal region responsible for a 3.7-fold induction, and 2) a -517/ -214 distal region responsible for potentiation of cAMP response up to 13-fold. In the -214/-100 region, we studied eutopic endometrial and endometriotic nuclear protein binding to a nuclear receptor half-site (NRHS, AGGTCA) and an imperfect cAMP response element (TGCACGTCA). Using electrophoretic mobility shift assay, cAMP response element-binding activity in nuclear proteins from both endometriotic and eutopic endometrial cells gave rise to formation of identical DNA-protein complexes. The NRHS probe, on the other hand, formed a distinct complex with nuclear proteins from endometriotic cells, which migrated at a much faster rate compared with the complex formed with nuclear proteins from eutopic endometrial cells. Employing recombinant proteins and antibodies against steroidogenic factor-1 (SF-1) and chicken ovalbumin upstream promoter transcription factor (COUP-TF), we demonstrated that COUP-TF but not SF-1 bound to NRHS in eutopic endometrial cells, whereas SF-1 was the primary NRHS-binding protein in endometriotic cells. In fact, COUP-TF transcripts were present in both eutopic endometrial (n = 12) and endometriotic tissues (n = 8), whereas SF-1 transcripts were detected in all endometriotic tissues (n = 12), but in only 3 of 15 eutopic endometrial tissues. Moreover, we demonstrated a dose-dependent direct competition between SF-1 and COUP-TF for occupancy of the NRHS, to which SF-1 bound with a higher affinity. Finally, overexpression of SF-1 in eutopic endometrial and endometriotic cells strikingly potentiated baseline and cAMP-induced activities of -517 promoter II construct, whereas overexpression of COUP-TF almost completely abolished these activities. In conclusion, COUP-TF might be one of the factors responsible for the inhibition of P450arom expression in eutopic endometrial stromal cells, which lack SF-1 expression in the majority (80%) of the samples; in contrast, aberrant SF-1 expression in endometriotic stromal cells can override this inhibition by competing for the same DNA-binding site, which is likely to account for high levels of baseline and cAMP-induced aromatase activity.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (48)
- Aromatase expression in endometriosis via openalex
- Aromatase expression in endometriosis via openalex
- Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol via openalex
- Endometriosis via openalex
- Endometriosis and infertility: new concepts via openalex
- Endometriosis-associated pelvic pain: evidence for an association between the stage of disease and a history of chronic pelvic pain via openalex
- Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression via openalex
- Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro via openalex
- Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis via openalex
- Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Treatment of severe postmenopausal endometriosis with an aromatase inhibitor via openalex
- W2035426895 via openalex
- W2037984842 via openalex
- W2060333964 via openalex
- W2068935255 via openalex
- W2069968362 via openalex
- W2076046059 via openalex
- W2081917625 via openalex
- W2092178833 via openalex
- W2099423538 via openalex
- W2100859941 via openalex
- W2108388593 via openalex
- W2126100083 via openalex
- W2128003724 via openalex
- W2136657922 via openalex
- W2146582325 via openalex
- W4243180786 via openalex
- W4285719527 via openalex
- W6604006680 via openalex
- W6656356435 via openalex
- W6657460548 via openalex
- W6664125244 via openalex
- W6675112554 via openalex
- W6681973680 via openalex
- W97536107 via openalex
- W6814680148 via openalex
- W1547162940 via openalex
- W1798183867 via openalex
- W1965137510 via openalex
- W1972767512 via openalex
- W1984828684 via openalex
- W1989404311 via openalex
- W1993243592 via openalex
- W2002196249 via openalex
- W2018336213 via openalex
- W2027395750 via openalex
- W2032413102 via openalex
Cited by (50)
- Shared Biology Underlying Benign Endometrial Diseases and Endometrial Cancer: Current Knowledge and Future Prospectives 2026
- Endometriosis and ovulatory menstruation: beyond the Sampson principle 2025
- The use of hormonal contraceptives in fertility treatments: a committee opinion 2024
- The use of hormonal contraceptives in fertility treatments: a committee opinion 2024
- Network pharmacology and experimental validation to explore the potential mechanism of Sanjie Zhentong Capsule in endometriosis treatment 2023
- Novel therapeutic targets to improve IVF outcomes in endometriosis patients: a review and future prospects 2021
- Three-Dimensional Biofabrication Models of Endometriosis and the Endometriotic Microenvironment 2020
- Endometriosis-Associated Macrophages: Origin, Phenotype, and Function 2020
- Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells 2020
- Endometriosis: The Role of Iron Overload and Ferroptosis 2020
- Steroid hormones regulate genome-wide epigenetic programming and gene transcription in human endometrial cells with marked aberrancies in endometriosis 2020
- Three-Dimensional Biofabrication Models of Endometriosis and the Endometriotic Microenvironment 2020
- Endometriosis and nuclear receptors 2019
- Endometriosis 2019
- Local estrogen formation and its regulation in endometriosis 2019
- Peroxisome proliferator-activated receptor-γ coactivator 1α-mediated pathway as a possible therapeutic target in endometriosis 2019
- Endometriosis 2019
- Endometriosis 2019
- Hypoxia: The force of endometriosis 2019
- Aromatase as a target for treating endometriosis 2018
- Farnesoid X Receptor Agonist GW4064 Inhibits Aromatase and ERβ Expression in Human Endometriotic Stromal Cells 2018
- Farnesoid X Receptor Agonist GW4064 Inhibits Aromatase and ERβ Expression in Human Endometriotic Stromal Cells 2018
- Increased circulating miR-370-3p regulates steroidogenic factor 1 in endometriosis 2018
- Transcription factor 21 regulates expression of ERβ and SF-1 via upstream stimulatory factor-2 in endometriotic tissues 2018
- DNA hypomethylation of the nuclear receptor subfamily 5 (NR5A1) gene promoter is associated with endometriosis among women in north west of Iran 2018
- SULFATION PATHWAYS: Contribution of intracrine oestrogens to the aetiology of endometriosis 2018
- Drug delivery for the treatment of endometriosis and uterine fibroids 2017
- PRL-3 Is Involved in Estrogen- and IL-6-Induced Migration of Endometrial Stromal Cells From Ectopic Endometrium 2016
- IGF-I stimulates ERβ and aromatase expression via IGF1R/PI3K/AKT-mediated transcriptional activation in endometriosis 2016
- Functional Expression of FSH Receptor in Endometriotic Lesions 2016
- Association between mRNA Expression of Aromatase, 17β-HSD2, Level of TGF-β1 and Stage of Endometriosis 2016
- DNA methylation in endometriosis (Review) 2016
- Smad3/4 Binding to Promoter II of P450arom So As to Regulate Aromatase Expression in Endometriosis 2016
- Metformin Suppresses Prostaglandin E2-Induced Cytochrome P450 Aromatase Gene Expression and Activity via Stimulation of AMP-Activated Protein Kinase in Human Endometriotic Stromal Cells 2015
- Arrays to detect Erring Factors of Endometrial Origin in Endometriosis 2015
- Comparing protective effect of grape seed extract versus atorvastatin on endometriosis in rat model: Evidence for immunohistochemical and biochemical alterations 2015
- Animal Models in Endometriosis Research 2015
- Epigenetics in Endometriosis 2014
- A low-testosterone state associated with endometrioma leads to the apoptosis of granulosa cells 2014
- Peroxisome proliferator-activated receptor gamma, coactivator 1α enhances local estrogen biosynthesis by stimulating aromatase activity in endometriosis 2014
- Estrogen receptor (ER) agonists differentially regulate neuroangiogenesis in peritoneal endometriosis via the repellent factor SLIT3 2014
- Peptide inhibitors of angiogenesis in endometriosis and the female reproductive system 2014
- Suppression of COUP-TFII by proinflammatory cytokines contributes to the pathogenesis of endometriosis 2014
- Molecular aspects of development and regulation of endometriosis 2014
- Role of Aromatase Inhibitors in the Treatment of Endometriosis 2014
- Sex Steroids and Endometriosis 2014
- Roles of Prostaglandin E2 in Endometriosis 2014
- Endometriosis 2013
- Inducers of G-protein coupled estrogen receptor (GPER) in endometriosis: potential implications for macrophages and follicle maturation 2013
- COUP-TFII regulates human endometrial stromal genes involved in inflammation 2013
Source provenance
- europepmc
- last seen: 2026-10-12T06:17:10.165071+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T22:00:54.229014+00:00
License: CC0
· commercial use OK